), and a higher MB concentration (32 μM, SK 23, Rice et al. 5 ) are plotted together for comparison.
SI Text Methylene blue dark toxicity and phototoxicity
Methylene blue (MB) is a high-efficiency photosensitizer and can be used for inactivation of viruses, bacteria and tumor cells by photodynamic actions. It has been shown to be safe in humans and is now clinically used for PDT on some types of cancers, virus and bacterial infections in some countries. 1 Methylene blue's phototoxicity has been investigated on different types of mammalian cancer cells, non-cancer cells, bacterial cells, and virus cells. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] However, its specific efficacy on C6 cells has been lacking. In our tests, dark toxicity of MB was examined first before we performed full PDT screening. We confirmed that a concentration up to 10 μM and an incubation time up to 1 hour gave no or only marginal dark toxicity for C6 cells (at least 95% viable cells) in all tests.
In Fig. S6 , we summarized our MB efficacy test results on C6 cells and compared with the other previous works. First, the effect of MB concentration on cell viability is shown in Fig. S6 (a) . Here the C6 cells were exposed to a fixed fluence of 57.5 J/cm 2 under atmospheric conditions. As the MB concentration increases, a concurrent decrease in cell viability was observed, with a high viability at below 1 μM while less than 5% of the cells survived above 7. with VSV and HSV cells that under a higher fluence (estimated around 279 J/cm 2 ), a higher MB phototoxicity was observed, and also a much faster drop in viability as the concentration increases. 6 The effect of the ambient oxygen level on the C6 cells viability is shown in Fig. S6 (b) . Cells were cultured with 10 μM MB and exposed to a fixed fluence of 71.9 J/cm 2 . As the oxygen level increases, a concurrent decrease in cell viability was observed, from a high level (~ 90%) under hypoxia conditions to a low level (below 5%) with a higher oxygen supply. Unfortunately, no specific report has been found for the MB's phototoxicity dependence on oxygen level; this could be, in part, because controlling the oxygen level is challenging for conventional biomedical tests. However, the influence of hypoxia conditions on PDT treatments has been well recognized and some results, using other photosensitizers, have been reported. [7] [8] [9] [10] [11] Wyld et al. tested aminolaevulinic acid (ALA) phototoxicity on HT 1197 cells under both hypoxic and normoxic conditions. 11 It was reported that there was an obvious viability improvement under low oxygen levels (0%, 2.5%, 5%) but no significant difference was found at higher levels (7.5%, 10%). From another perspective, Chapman et al. also demonstrated that, under hypoxia conditions a much longer illumination time was required for Photofrin II to kill the same amount of EMT-6 cells. 8 The effect of fluence on the C6 cells' viability is shown in Fig. 8 (c) . Cells were cultured with 10 μM MB and illuminated with a series of fluences (up to 71.9 J/cm 2 ) under atmospheric conditions. As the fluence increases, a concurrent decrease in cell viability was observed, with a high viability (> 90%) at 71. 
